- Behind Low Vaccination Rates Lurks a More Profound Social Weakness
- Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
- Fort Collins Patient Testimony Q&A
- RSV Knowledge with Tekton’s Principal Investigator, Clint Flanagan, M.D.
- RSV in Older Adults and Adults with Chronic Medical Conditions